Composition for treating virus infection disease comprising Jab1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO

8226944

APP PUB NO

20110092414A1

SERIAL NO

12909443

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a Jab1 protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITYGYEONGGI-DO342

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lee, Han-Woong Seongnam-si, KR 5 0
Lee, Sung Ryul Yongin-si, KR 3 1
Oh, Wonkyung Gwangju, KR 2 0
Pyo, Suhk Neung Seoul, KR 3 0
Song, Jaewhan Seongnam-si, KR 1 0
Sung, Young Hoon Suwon-si, KR 3 12
Yang, Joo-Sung Seoul, KR 12 36

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Takeda Chemical Industries, Ltd. (1)
5948883 Human CRM1 Protein 1 1997
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 24, 2020
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 24, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00